Status:
TERMINATED
Homeopathy for Prevention of Atrial Fibrillation After Aortocoronary Bypass Surgery
Lead Sponsor:
Medical University of Vienna
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18-100 years
Phase:
PHASE4
Brief Summary
After heart surgery, about 30% of patients suffer from atrial fibrillation. Patients are randomized into two groups receiving either potentized Strychnos Nux vomica or placebo under double blind condi...
Detailed Description
Preoperatively, patients receive potentized Nux vomica or placebo sublingually. Then, patients are observed regarding atrial fibrillation postsurgical. The difference between the group of patients wit...
Eligibility Criteria
Inclusion
- Patients before elective Heart valve - or aortocoronary by pass surgery with heart-lung-machine.
Exclusion
- Pregnant patients
- Patients with preoperative atrial fibrillation and/or hyperthyreosis
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2017
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00861237
Start Date
July 1 2008
End Date
November 1 2017
Last Update
August 16 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept Surgery, Med Univ Vienna
Vienna, Austria, A1090